Karl Swedberg

Research interests

Publications

• Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure

  Circulation · 2019 · https://doi.org/10.1161/circulationaha.119.044586

• Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

  New England Journal of Medicine · 2014 · https://doi.org/10.1056/nejmoa1409077

• Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

  Circulation · 2014 · https://doi.org/10.1161/circulationaha.114.013748

• Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

  European Heart Journal · 2012 · https://doi.org/10.1093/eurheartj/ehs337

• Person-Centered Care — Ready for Prime Time

  European Journal of Cardiovascular Nursing · 2011 · 10.1016/j.ejcnurse.2011.06.008

• Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1100171

• Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

  New England Journal of Medicine · 2010 · 10.1056/nejmoa1009492

• Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

  The Lancet · 2010 · 10.1016/s0140-6736(10)61198-1

• Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial

  The Lancet · 2010 · 10.1016/s0140-6736(10)61259-7

• ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008

  European Journal of Heart Failure · 2008 · 10.1016/j.ejheart.2008.08.005

• Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure

  Journal of the American College of Cardiology · 2007 · 10.1016/j.jacc.2007.02.067

• Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure

  Circulation · 2006 · 10.1161/circulationaha.105.580506

• Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi204

• Executive summary of the guidelines on the diagnosis and treatment of acute heart failure

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi044

• Predictors of mortality and morbidity in patients with chronic heart failure

  European Heart Journal · 2005 · 10.1093/eurheartj/ehi555

• Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients

  Circulation · 2005 · 10.1161/circulationaha.105.561423

• Targeted Anticytokine Therapy in Patients With Chronic Heart Failure

  Circulation · 2004 · 10.1161/01.cir.0000124490.27666.b2

• CHARM IN-VESTIGATORS AND COMMITTEES. EFFECTS OF CANDESARTAN IN PATIENTS WITH CHRONIC HEART FAILURE AND REDUCED LEFT-VENTRICULAR SYSTOLIC FUNCTION TAKING ANGIOTENSIN-CONVERTING-ENZYME INHIBITORS: THE CHARM-ADDED TRIAL

  The Lancet · 2003

• Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

  New England Journal of Medicine · 2003 · 10.1056/nejmoa032292

• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14285-7

• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14283-3

• Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

  The Lancet · 2003 · 10.1016/s0140-6736(03)14282-1

• Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)14284-5

• Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

  The Lancet · 2003 · 10.1016/s0140-6736(03)13800-7

• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy

  The Lancet · 1993 · 10.1016/0140-6736(93)92930-r

• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

  Circulation · 1990 · 10.1161/01.cir.82.5.1730

• Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

  The American Journal of Cardiology · 1988 · 10.1016/s0002-9149(88)80087-0

• EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION

  The Lancet · 1981 · 10.1016/s0140-6736(81)91101-6

Current projects

No projects listed.